NASDAQ:CVET • US22304C1009
ChartMill assigns a Buy % Consensus number of 51% to CVET. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-06-13 | Stifel | Downgrade | Buy -> Hold |
| 2022-05-26 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2022-05-25 | William Blair | Downgrade | Outperform -> Market Perform |
| 2022-05-23 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2022-05-23 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-05-19 | Goldman Sachs | Maintains | Sell |
| 2022-05-09 | Barclays | Maintains | Overweight |
| 2022-05-06 | Raymond James | Maintains | Outperform |
| 2021-11-18 | Morgan Stanley | Initiate | Equal-Weight |
| 2021-11-05 | Raymond James | Maintains | Outperform |
| 2021-08-09 | Barclays | Maintains | Overweight |
| 2021-08-06 | Raymond James | Maintains | Outperform |
| 2021-07-12 | Guggenheim | Upgrade | Neutral -> Buy |
| 2021-03-02 | Raymond James | Maintains | Outperform |
| 2021-02-17 | Barclays | Initiate | Overweight |
11 analysts have analysed CVET and the average price target is 21.76 USD. This implies a price increase of 3.67% is expected in the next year compared to the current price of 20.99.
The consensus rating for Covetrus Inc (CVET) is 50.9091 / 100 . This indicates that analysts generally have a neutral outlook on the stock.